EMEA-002184-PIP01-17

Key facts

Active substance
(R)-2-amino-3-phenylpropylcarbamate hydrochloride (solriamfetol)
Therapeutic area
Neurology
Decision number
P/0207/2018
PIP number
EMEA-002184-PIP01-17
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
  • Treatment of narcolepsy
  • Treatment of obstructive sleep apnoea
Route(s) of administration
Oral use
Contact for public enquiries
Jazz Pharmaceuticals UK Ltd

Tel.  +44 7384460309
E-mail: stewart.cole@jazzpharma.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating